How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

99

HKG:9939
Get a brief AI stock analysisSaves ~ 15 minutes of your time

99

Kintor Pharmaceutical LtdHKG 9939 Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XHKG - Hong Kong Exchange

FAIR VALUE

Is 9939 undervalued compared to its fair value?

The fair value of 9939 stock is hidden HKD. Relative to the market price of 1.06 HKD Kintor Pharmaceutical Ltd is hidden.

Kintor Pharmaceutical Ltd. is a clinical-stage novel drug developer in China, which focuses on the proprietary research and development of innovative medicine products for cancers and other Androgen receptor-related dise...[More about valuation]

Kintor Pharmaceutical Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0.06 $B

Price:

1.06 HKD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.495

FINANCIALS

Kintor Pharmaceutical financial for reporting period

Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.22 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.21 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

Balance Sheet

1.9 B
1.3 B

Financial Position Analysis

Assets

1.9 B
Current Assets
1.3 B
Total non-current assets
0.54 B

Total current liabilities
0.27 B
Total non-current liabilities
0.27 B

Cash Flow Statement

-N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.21 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Kintor Pharmaceutical fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is 9939 attractive for investment based on fundamental analysis?

9939 stock rating is hidden. Kintor Pharmaceutical is a hidden by Eyestock methodology.

Get 9939 Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

Gross Margin:

CFO / Debt ratio:

hidden

Current ratio:

Debt / Equity ratio:

ROE:

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

9939.HK analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for 9939.HK to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Kintor Pharmaceutical Ltd competitors

AB

ABBV

Abbvie Inc

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Ill...

Discover

AM

AMGN

Amgen Inc

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company...

Discover

VR

VRTX

Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs fo...

Discover

Kintor Pharmaceutical Ltd dividends

9939.HK dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About 9939.HK stock

About the company Kintor Pharmaceutical Ltd

Market cap $B

0.06

Dividend yield

Shares outstanding

435.829925 B

Kintor Pharmaceutical Ltd. is a clinical-stage novel drug developer in China, which focuses on the proprietary research and development of innovative medicine products for cancers and other Androgen receptor-related diseases. The company is headquartered in Suzhou, Jiangsu and currently employs 328 full-time employees. The company went IPO on 2020-05-22. The firm is focused on the research and development of drugs for cancers and other androgen receptor (AR) related diseases. Its primary drug candidate is Proxalutamide which is in phase III clinical trials in China for metastatic castration-resistant prostate cancer (mCRPC). The firm are also developing other drug candidates, including a phase II small molecule drug candidate Pyrilutamide, a phase II monoclonal antibody drug candidate ALK-1, a phase I mTOR inhibitor drug candidate Detorsertib and an inhibitor of the hedgehog signal translation pathway GT1708F.

9939.HK profile

  • Ticker

    9939.HK

  • Country

    China

  • Exchange

    XHKG - Hong Kong Exchange

  • Report currency

    CNY - Chinese yuan

  • IPO date

    22 May 2020

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

    328

  • City

    Suzhou

  • Address

    No.20 Songbei Road, Suzhou Industrial Park

  • Cusip

    G5273B107

9939.HK market tickers

OOTC - OTC

KNTPF